LRP11 and cervical cancer: Among the LDLR family members, LRP11 was recently identified as a prognostic marker and therapeutic target in prostate and cervical cancers (Wang et al., 2019; Gan et al., 2020; Gu et al., 2023); however, the underlying association and role of LRP11 in LIHC remain unknown.